PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 64 filers reported holding PAIN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $23,000 | -80.7% | 42,000 | -64.9% | 0.00% | -80.0% |
| Q3 2016 | $119,000 | +190.2% | 119,700 | +438.1% | 0.01% | +66.7% |
| Q1 2015 | $41,000 | -61.3% | 22,244 | -57.5% | 0.01% | -66.7% |
| Q4 2014 | $106,000 | -59.7% | 52,400 | -22.3% | 0.02% | -55.0% |
| Q3 2014 | $263,000 | -59.7% | 67,400 | -40.8% | 0.04% | -58.8% |
| Q2 2014 | $653,000 | +115.5% | 113,800 | +105.8% | 0.10% | +106.4% |
| Q1 2014 | $303,000 | +352.2% | 55,300 | +297.8% | 0.05% | +291.7% |
| Q4 2013 | $67,000 | – | 13,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Street Partners, LLC | 1,707,764 | $9,819,643,000 | 9.95% |
| SOPHROSYNE CAPITAL LLC | 951,362 | $5,472,000 | 5.57% |
| GREAT POINT PARTNERS LLC | 1,694,256 | $9,742,000 | 4.33% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 436,148 | $2,508,000 | 2.19% |
| AVALON CAPITAL MANAGEMENT | 110,837 | $637,000 | 0.53% |
| Visium Asset Management, LP | 4,350,000 | $25,013,000 | 0.39% |
| Cheyne Capital Management (UK) LLP | 25,000 | $144,000 | 0.17% |
| Gruss Capital Management LP | 600,000 | $3,450,000 | 0.17% |
| Capital Impact Advisors, LLC | 31,206 | $179,000 | 0.14% |
| TFS CAPITAL LLC | 292,036 | $1,679,000 | 0.13% |